223 related articles for article (PubMed ID: 17316369)
1. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
3. The tularaemia vaccine.
Sandström G
J Chem Technol Biotechnol; 1994 Apr; 59(4):315-20. PubMed ID: 7764815
[TBL] [Abstract][Full Text] [Related]
4. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
5. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
6. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
7. Vaccines against tularemia.
Barry EM; Cole LE; Santiago AE
Hum Vaccin; 2009 Dec; 5(12):832-8. PubMed ID: 19923904
[TBL] [Abstract][Full Text] [Related]
8. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
Cherwonogrodzky JW; Knodel MH; Spence MR
Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
[TBL] [Abstract][Full Text] [Related]
9. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB;
Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854
[TBL] [Abstract][Full Text] [Related]
10. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
[TBL] [Abstract][Full Text] [Related]
11. [The glycolipid composition of Francisella tularensis strains with different degrees of attenuation].
Sukhar' VV
Mikrobiol Zh (1978); 1993; 55(1):8-12. PubMed ID: 8446062
[TBL] [Abstract][Full Text] [Related]
12. Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
Whelan AO; Flick-Smith HC; Homan J; Shen ZT; Carpenter Z; Khoshkenar P; Abraham A; Walker NJ; Levitz SM; Ostroff GR; Oyston PCF
PLoS One; 2018; 13(10):e0200213. PubMed ID: 30296254
[TBL] [Abstract][Full Text] [Related]
13. A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
Whelan AO; Flick-Smith HC; Walker NJ; Abraham A; Levitz SM; Ostroff GR; Oyston PCF
PLoS One; 2024; 19(5):e0294998. PubMed ID: 38713688
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
Aronova NV; Pavlovich NV
Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
[TBL] [Abstract][Full Text] [Related]
15. [Tularemia vaccine strain is a potential vector].
Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
[TBL] [Abstract][Full Text] [Related]
16. [The dynamics of antibody formation to a vaccinal strain of Francisella tularensis in different immunization regimens].
Cherepakhina IIa; Kozlovskiĭ VN; Efanova EA; Novokhatskiĭ AS; Alekseeva LP; Sukhar' VV; Prozorova LA; Larionova LV; Sorokin VM; Lysova LK
Mikrobiol Zh (1978); 1990; 52(2):89-93. PubMed ID: 2377086
[TBL] [Abstract][Full Text] [Related]
17. Live tularemia vaccine but not proteins purified from Francisella tularensis can confer protection against lethal Listeria infection in mice.
Belyi YF; Petrosov VV; Tartakovskii IS; Suchkov YG
APMIS; 1995 Feb; 103(2):107-12. PubMed ID: 7748535
[TBL] [Abstract][Full Text] [Related]
18. [The cytogenetic action of x-ray irradiation on the myelokaryocytes of rats immunized with a tularemia vaccine].
Nersesian AK; Kumkumadzhian VA; Zil'fian VN
Tsitol Genet; 1989; 23(6):15-8. PubMed ID: 2623763
[TBL] [Abstract][Full Text] [Related]
19. Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain.
Havlasová J; Hernychová L; Halada P; Pellantová V; Krejsek J; Stulík J; Macela A; Jungblut PR; Larsson P; Forsman M
Proteomics; 2002 Jul; 2(7):857-67. PubMed ID: 12124931
[TBL] [Abstract][Full Text] [Related]
20. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence.
Fulop M; Manchee R; Titball R
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):245-7. PubMed ID: 8861037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
